中华放射学杂志
中華放射學雜誌
중화방사학잡지
Chinese Journal of Radiology
2013年
1期
49-54
,共6页
顾秀玲%李明华%李永东%孙贞魁%谭华桥%王武%顾斌贤%陈元畅
顧秀玲%李明華%李永東%孫貞魁%譚華橋%王武%顧斌賢%陳元暢
고수령%리명화%리영동%손정괴%담화교%왕무%고빈현%진원창
颅内动脉瘤%磁共振成像%血管造影术,数字减影%对比研究
顱內動脈瘤%磁共振成像%血管造影術,數字減影%對比研究
로내동맥류%자공진성상%혈관조영술,수자감영%대비연구
Intracranial aneurysm%Magnetic resonance imaging%Angiography,digital subtraction%Comparative study
目的 以DSA为对照,研究3.0 T MR VR重组三维时间飞跃法(3D-TOF) MRA诊断颅内动脉瘤的准确性.方法 411例可疑颅内动脉瘤或其他脑血管疾病的患者在行DSA检查前进行3D-TOF-MRA检查,MRA检查后2周内进行DSA检查,以2D-DSA和VR-DSA结果作为金标准.42例患者被排除(6例因运动伪影被排除,36例因缺少VR-DSA数据被排除).从每例患者有无动脉瘤、每枚动脉瘤和动脉瘤大小(<3 mm、3~5 mm、>5 ~10 mm、>10 mm)3方面评估VR 3D-TOF-MRA对颅内动脉瘤诊断的准确性、敏感度和特异度.结果 在最终入选的369例患者中,VR-DSA在246例患者中检测到306枚颅内动脉瘤,123例患者无动脉瘤;3D-TOF-MRA在249例患者中检测到311枚颅内动脉瘤,120例患者无动脉瘤.从患者方面评估,VR 3D-TOF-MRA对颅内动脉瘤的诊断准确性、敏感度和特异度依次为97.6% (360/369)、99.2% (242/244)和94.4% (118/125);从动脉瘤方面评估,VR 3D-TOF-MRA的诊断准确性、敏感度和特异度依次为98.3% (524/533)、99.3%(304/306)和96.1% (220/229);基于动脉瘤大小(<3 mm)的评估,VR 3D-TOF-MRA的诊断准确性、敏感度和特异度依次为96.4% (214/222)、98.2% (112/114)和94.4% (102/108).结论 VR 3D-TOF-MRA能准确诊断颅内动脉瘤,并可以作为一种无创、无辐射和无须对比剂的检查方法来替代DSA诊断和筛查颅内动脉瘤.
目的 以DSA為對照,研究3.0 T MR VR重組三維時間飛躍法(3D-TOF) MRA診斷顱內動脈瘤的準確性.方法 411例可疑顱內動脈瘤或其他腦血管疾病的患者在行DSA檢查前進行3D-TOF-MRA檢查,MRA檢查後2週內進行DSA檢查,以2D-DSA和VR-DSA結果作為金標準.42例患者被排除(6例因運動偽影被排除,36例因缺少VR-DSA數據被排除).從每例患者有無動脈瘤、每枚動脈瘤和動脈瘤大小(<3 mm、3~5 mm、>5 ~10 mm、>10 mm)3方麵評估VR 3D-TOF-MRA對顱內動脈瘤診斷的準確性、敏感度和特異度.結果 在最終入選的369例患者中,VR-DSA在246例患者中檢測到306枚顱內動脈瘤,123例患者無動脈瘤;3D-TOF-MRA在249例患者中檢測到311枚顱內動脈瘤,120例患者無動脈瘤.從患者方麵評估,VR 3D-TOF-MRA對顱內動脈瘤的診斷準確性、敏感度和特異度依次為97.6% (360/369)、99.2% (242/244)和94.4% (118/125);從動脈瘤方麵評估,VR 3D-TOF-MRA的診斷準確性、敏感度和特異度依次為98.3% (524/533)、99.3%(304/306)和96.1% (220/229);基于動脈瘤大小(<3 mm)的評估,VR 3D-TOF-MRA的診斷準確性、敏感度和特異度依次為96.4% (214/222)、98.2% (112/114)和94.4% (102/108).結論 VR 3D-TOF-MRA能準確診斷顱內動脈瘤,併可以作為一種無創、無輻射和無鬚對比劑的檢查方法來替代DSA診斷和篩查顱內動脈瘤.
목적 이DSA위대조,연구3.0 T MR VR중조삼유시간비약법(3D-TOF) MRA진단로내동맥류적준학성.방법 411례가의로내동맥류혹기타뇌혈관질병적환자재행DSA검사전진행3D-TOF-MRA검사,MRA검사후2주내진행DSA검사,이2D-DSA화VR-DSA결과작위금표준.42례환자피배제(6례인운동위영피배제,36례인결소VR-DSA수거피배제).종매례환자유무동맥류、매매동맥류화동맥류대소(<3 mm、3~5 mm、>5 ~10 mm、>10 mm)3방면평고VR 3D-TOF-MRA대로내동맥류진단적준학성、민감도화특이도.결과 재최종입선적369례환자중,VR-DSA재246례환자중검측도306매로내동맥류,123례환자무동맥류;3D-TOF-MRA재249례환자중검측도311매로내동맥류,120례환자무동맥류.종환자방면평고,VR 3D-TOF-MRA대로내동맥류적진단준학성、민감도화특이도의차위97.6% (360/369)、99.2% (242/244)화94.4% (118/125);종동맥류방면평고,VR 3D-TOF-MRA적진단준학성、민감도화특이도의차위98.3% (524/533)、99.3%(304/306)화96.1% (220/229);기우동맥류대소(<3 mm)적평고,VR 3D-TOF-MRA적진단준학성、민감도화특이도의차위96.4% (214/222)、98.2% (112/114)화94.4% (102/108).결론 VR 3D-TOF-MRA능준학진단로내동맥류,병가이작위일충무창、무복사화무수대비제적검사방법래체대DSA진단화사사로내동맥류.
Objective To investigate the diagnostic accuracy of contrast-free three dimensional time-of-flight (3D-TOF-MRA) with VR at 3.0 T in the detection of intracranial aneurysms in a large cohort of patients prospectively.Methods Four hundred and eleven patients with suspected aneurysms and other cerebral vascular diseases received contrast-free 3D-TOF-MRA examinations at 3.0 T MRA 2 weeks prior to DSA examination.2D-DSA and VR-DSA were regarded as the gold standard.Six patients were excluded because of motion artifacts,and 36 patients were excluded due to lack of VR-DSA data.Accuracy,sensitivity an specificity in detecting intracranial aneurysms were determined by patient-,aneurysm-,and aneurysm sizebased (< 3 mm,3-5 mm,> 5-10 mm,> 10 mm) evaluations.Results In 369 enrolled patients,VR-DSA revealed 306 aneurysms in 246 patients (66.7%) and no aneurysm in 123 patients; VR 3D-TOF-MRA revealed 311 aneurysms in 249 patients and no aneurysm in 120 patients.The patient-based evaluation of VR 3 D-TOF-MRA at 3.0T yielded accuracy of 97.6% (360/369),sensitivity of 99.2% (242/244),and specificity of 94.4% (118/125) in the detection of intracranial aneurysms.The aneurysm-based evaluation yielded accuracy of 98.3% (524/533),sensitivity of 99.3% (304/306),and specificity of 96.1%(220/229).The evaluation based on aneurysm sizes (< 3 mm) yielded accuracy of 96.4% (214/222),sensitivity of 98.2% (112/114),and specificity of 94.4% (102/108).Conclusion VR 3D-TOF-MRA at 3.0 T MR can detect intracranial aneurysms accurately and may replace DSA as a contrast-free,noninvasive and non-radiation-based modality for the diagnosis and screening of intracranial aneurysms.